Watch: the CureRays® explainer series
Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.
What is acinic cell carcinoma (salivary gland)?
Acinic cell carcinoma is a type of salivary-gland cancer that begins in the cells that normally produce saliva. It is most common in the parotid gland — the large salivary gland in front of and below the ear — but can also arise in smaller salivary glands. Most acinic cell carcinomas are low-grade, meaning they tend to grow slowly and rarely spread, and they carry an excellent long-term outlook. It is one of the more common salivary cancers in younger adults and even occasionally in children. In recent years, doctors have learned that some tumors once labeled 'acinic cell carcinoma' are actually a separate, gene-fusion-driven cancer called secretory carcinoma; modern testing now distinguishes the two, because the treatments and outlooks can differ. A small minority of acinic cell carcinomas are high-grade or undergo 'high-grade transformation,' behaving more aggressively and requiring more intensive treatment.
The main types
Doctors group acinic cell carcinoma (salivary gland) by where it starts and how it behaves:
| Type | What it means, simply |
|---|---|
| Conventional low-grade acinic cell carcinoma | The usual form — slow-growing, rarely spreads, and usually cured with surgery. Most patients fall into this group with an excellent outlook. |
| High-grade transformed acinic cell carcinoma | An uncommon, more aggressive version that has changed to a higher grade, with a greater chance of spreading to lymph nodes or distant sites and needing surgery plus radiation. |
Staging, in plain terms
Acinic cell carcinoma is staged with the standard TNM system for salivary-gland cancers — the size and reach of the tumor (T), spread to neck lymph nodes (N), and spread to distant organs (M) — combined with the tumor's grade. Because most cases are low-grade and caught early, they fall into earlier stages with a very high cure rate. The uncommon high-grade tumors are staged the same way but behave more aggressively.
| Head-and-neck (salivary) TNM + grade | What it generally means |
|---|---|
| Early, low-grade | A small tumor confined to the gland. Usually cured with surgery alone, with an excellent long-term outlook. |
| Larger or node-positive | A bigger tumor, or spread to neck lymph nodes. Treated with surgery plus radiation to the gland area and neck to improve control. |
| High-grade or metastatic | Aggressive or distant disease. Treated with surgery and radiation where possible, with systemic therapy or clinical trials considered for widespread disease. |
The standard of care
Acinic Cell Carcinoma (Salivary Gland) is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:
Surgery (the main treatment)
Removing the tumor — for example, removing part or all of the parotid gland while carefully protecting the facial nerve — is the primary treatment and cures most low-grade tumors.
Neck lymph-node evaluation
For higher-grade or larger tumors, the neck lymph nodes are assessed and removed or treated when there is a meaningful risk of spread.
Radiation therapy
Radiation is added after surgery for high-grade tumors, close or positive margins, nerve involvement, or lymph-node spread, and it can be the main treatment when surgery is not possible.
Systemic therapy for advanced disease
For the rare cases that spread widely, chemotherapy, targeted therapy, or clinical trials are considered, since standard chemotherapy has limited benefit for this slow-growing cancer.
How radiation treatment works
Radiation damages the DNA inside cancer cells so they can no longer divide. For acinic cell carcinoma, surgery is usually the main treatment, but radiation is an important partner after surgery when the tumor is high-grade, the margins are close or positive, a nerve is involved, or lymph nodes are affected — it treats the microscopic cells left behind and lowers the chance of the cancer returning. Intensity-modulated radiation shapes the dose around the salivary region and neck while sparing healthy glands and swallowing muscles. For tumors near the skull base or those needing re-treatment, proton therapy can further spare nearby tissue. Radiation is painless during delivery, given over several weeks of daily sessions, and external-beam treatment leaves no radioactivity in the body.
The main ways radiation is delivered for acinic cell carcinoma (salivary gland):
Intensity-modulated radiation (IMRT)
Beams are shaped around the salivary region and neck to treat the tumor bed while sparing the other salivary glands, swallowing muscles, and jaw to limit dry mouth and other side effects.
Proton therapy (selected)
Protons can reduce dose to nearby structures for tumors near the skull base or when re-treating an area, lowering side effects.
Neutron / particle therapy (selected high-grade)
For certain aggressive salivary cancers that resist standard radiation, specialized particle beams at expert centers can improve local control.
Latest studies shaping care
Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:
Separating acinic cell from secretory carcinoma: The discovery that many tumors once called acinic cell carcinoma are actually a distinct gene-fusion cancer (secretory carcinoma) has refined diagnosis. Accurate testing now separates the two, which matters because secretory carcinoma can be treated with targeted NTRK-inhibitor pills.[1]
WHO salivary-gland tumor classification and surgical pathology literature
Excellent outcomes for low-grade disease: Large clinical series confirm that low-grade acinic cell carcinoma treated with surgery (with radiation for higher-risk features) has high long-term cure and survival rates.[2]
Head & Neck and Oral Oncology outcome series
High-grade transformation matters: Studies show that the small fraction of tumors with high-grade transformation behave far more aggressively, supporting careful pathology review and more intensive treatment for those cases.[3]
American Journal of Surgical Pathology transformation series
Common questions
Is acinic cell carcinoma usually serious? Most acinic cell carcinomas are low-grade and slow-growing, with an excellent outlook after surgery. A minority are high-grade or undergo high-grade transformation and behave more aggressively, needing surgery, radiation, and close follow-up. Your team bases the plan on your tumor's grade and stage.
Will I lose my facial movement after parotid surgery? The facial nerve runs through the parotid gland, so surgeons take great care to identify and protect it. Most patients keep normal facial movement; temporary weakness can occur and usually improves. Your surgeon will discuss the specific risks for your tumor's location.
Why does it matter to tell it apart from secretory carcinoma? The two look similar but are different cancers. Secretory carcinoma is defined by a gene fusion (ETV6-NTRK3) that makes targeted NTRK-inhibitor pills an option for advanced disease. Modern molecular testing distinguishes them so each is treated correctly.
References
Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.
- WHO salivary-gland tumor classification and surgical pathology literature (no indexed identifier — see your care team) ↩
- Head & Neck and Oral Oncology outcome series (no indexed identifier — see your care team) ↩
- American Journal of Surgical Pathology transformation series (no indexed identifier — see your care team) ↩